Doravirine 100mg / Lamivudine 300mg / Tenofovir disoproxil 245mg tablets
NHS hospitals in England used £50,361,717 of indicative cost of Doravirine 100mg / Lamivudine 300mg / Tenofovir disoproxil 245mg tablets in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is up 2.1% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Doravirine 100mg / Lamivudine 300mg / Tenofovir disoproxil 245mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Doravirine 100mg / Lamivudine 300mg / Tenofovir disoproxil 245mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Chelsea & Westminster Hospital Nhs Ft | £10,396,621 |
| Manchester University Nhs Ft | £5,133,648 |
| Guy's & St Thomas' Nhs Foundation Trust | £2,920,019 |
| Western Sussex Hospitals Nhs Found Trust | £2,520,742 |
| Imperial College Healthcare Nhs Trust | £2,448,424 |
| University College London Foundation Tr | £2,213,378 |
| Leeds Teaching Hpls Nhs Trust | £2,135,428 |
| Royal Free London Nhs Foundation Trust | £1,722,343 |
| Ctrl & N W London Nhs Foundation Trust | £1,581,987 |
| Aintree University Hospital Nhs Ft | £1,406,455 |
The primary-care picture
Doravirine is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Doravirine medicine page.